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Introduction
Transplanting new organs is a way of trying to deal with life 
threatening diseases. Instead of the chronic maintenance of dis-
eased organs medical professionals would be able to replace 
them, thus curing the condition. One leading major health cri-
sis is the shortage of organs available for transplants. Although 
medicine’s advancements help people live longer, organs tend 
to fail more often as a result of longer lifespans. For instance, 
in the United States, a name is added to the Transplant List 
on an average of every ten minutes. Additionally, the number 
of patients needing organs have doubled while the amount of 
transplant procedures has barely increased (OPTN, 2016). 3D 
organ printing technology is a promising step to help solve the 
organ transplantation crisis. 
The field of regenerative medicine deals with replacing, engi-
neering, or regenerating human cells, tissues, or organs in order 
to help achieve normal function. Regenerative medicine is not 
a new field; Alexis Carrel, a Nobel Prize winner, writes in his 
book, “The Culture of Organs” (Carrel, Lindbergh, 1938) about 
technologies that are still used today for blood vessel grafting.
Thomas Boland, self-described as the “grandfather of bioprint-
ing,” took an old Lexmark computer, emptied the ink cartridge 
and filled it with collagen instead. He then glued a thin, black 
silicon sheet onto blank paper and inserted it into the printer. 
He opened a Word document on his PC, typed his initials, and 
hit print. The paper came out with “TB” clearly presented in off-
white proteins. By 2000, Boland and his team had reconfigured 
a Hewlett-Packard DeskJet 550C to print with E. coli bacteria. 
Then they expanded to larger mammalian cells obtained from 
Chinese hamsters and lab rats. Once printed, 90 percent of the 
cells remained viable, which meant the product was useful , not 
only art. Boland introduced 3D printing for cellular construct 
when he patented the process for using the ink-jet printer for 
printing cells.  Boland’s process used a system where cells were 
deposited into 3D matrices placed on a substrate. Instead of 
using ink, 3D printers use cells in a cartridge where the cells are 
being layered in order to create a three-dimensional structure 
that can lead to functional organs and tissues (Wilson, Boland, 
2003). This paper will review the current progress in organ 
printing technology with its promises and challenges and evalu-
ate whether functional organs can be produced. 
Methods
The information in this paper was obtained by the analysis of 
scientific articles and research papers obtained from the Touro 
College Online Library, specifically, the Health Science relat-
ed databases such as Pubmed, Proquest Medical Library, and 
EBSCO multisearch. Additionally, websites like NIH.gov, Webmd.
com, Mayoclinic.com and OPTN.com were used to gain general 
knowledge and information about the subject. Keywords such 
as “3D organ printing” and “regenerative medicine” were used 
to search for scientific articles.
Discussion: The Bladder
At first, researchers were pipetting cells into petri dishes by 
hand without the use of 3D printers. To do so, researchers 
would seed the cells from the petri dishes onto artificial scaf-
folds; a suitable base for the organs. The scaffolds were made 
from biodegradable polymers or collagen which provided a 
temporary matrix for the cells to cling to until they were able 
to stand on their own. Dr. Anthony Atala, the lead researcher 
at Wake Forest Institute for Regenerative Medicine, implanted 
the first lab grown bladder organs into seven patients at Boston 
Children’s Hospital between 1999 and 2001 (Atala et. al., 2006). 
There are a variety of injuries that can lead to damage or loss 
of the bladder, requiring eventual replacement or repair of the 
organ. Children with congenital anomalies such as: bladder ex-
strophy, myelomeningocele, or posterior urethral valves, can 
develop high-pressure and hypertonic low compliant bladders. 
Often times, these patients require cystoplasty when drug 
treatment fails. Gastrointestinal segments are frequently used 
as donor tissues for cystoplasty. However, when such tissues 
are incorporated into the urinary tract, several complications 
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can ensue; such as metabolic disturbances, urolithiasis, increased 
mucous production, and malignant disease (Emedicine, 2016).
Atala, along with his research team, explored an alternative ap-
proach using autologous engineered bladder tissue for recon-
struction. Seven patients with myelomeningocele, aged 4-19 years 
old, with poorly compliant bladders were identified as candidates 
for cystoplasty.  Urethral and muscle cells from the patients 
were grown in a culture, and seeded on a biodegradable bladder 
shaped scaffold made of collagen, or a composite of collagen and 
polyglycolic acid. About seven weeks after biopsy, the autologous 
engineered bladder constructs were used for reconstruction and 
implanted into patients. Tests such as serial urodynamics, cyto-
grams, ultrasounds, bladder biopsies and serum analyses were 
performed. The bowel function of the patients returned to nor-
mal promptly after surgery with no metabolic consequences and 
renal function was preserved (Atala et. al., 2006). 
Researchers soon adopted 3-D printers to make scaffolds 
more precisely because manually placing the cells onto scaffold 
remained a time-consuming and arduous process. Engineered 
bladders were made possible because they can be made with 
just two cell types however, an organ such as a kidney consists 
of thirty cell types. When attempting to engineer more complex 
tissues, there is no way to manually place different cell types into 
different locations that can replicate the native tissue structures. 
Manual placement is not the optimal method for delivering cells 
(Murphy, Atala, 2014).
The Heart
The human heart is a complex biological machine. It pumps 
blood to all parts of the body, begins to beat three weeks after 
conception and does not stop until the day of death. It is re-
markable how the heart can last that long and function with the 
same redundancy and efficacy. The heart operates for billions of 
cycles, it is chemically powered and electrically synchronized. 
The heart is composed of over a hundred billion cells including 
cardiomyocytes, conduction system, fibroblasts, endothelial cells, 
smooth muscle cells and neurons. The main reason researchers 
are trying to 3D print the heart is because the heart is unable to 
regenerate itself and for this reason heart disease is the leading 
cause of death in first world countries (Mayo Clinic, 2016).
A heart transplant is a lifesaving procedure which removes a 
damaged or diseased heart and replaces it with a new one. 
Heart failures come as a result of different conditions such as 
coronary heart disease, damaged heart muscle or valves, con-
genital heart defects, or viral infections of the heart. Once the 
human heart is damaged, there is only a limited amount of re-
generation that can occur and may require a heart transplant. 
A heart transplant comes with many risks and complications 
such as infection or the recipient’s body attempting to reject 
the newly placed heart. To prevent rejection, the patients must 
immediately be given immunosuppressants as a lifelong treat-
ment (Mayo clinic, 2016). There are currently 4,138 candidates 
who are on the UNOS list for a heart transplant (OPTN, 2016). 
The high number of candidates results in an agonizing wait for 
a new heart which usually does not have a positive ending. This 
long waiting list can be reduced through the possibility of 3D 
printing of the human heart.
The hierarchical structure and function in the heart has levels 
that scales from the nanometer level up to the macroscopic 
level. Every heart beat is powered by molecular motors, the 
actin and myosin, which are only a few nanometers in size and 
generate pico newtons amount of force. The actin and myosin 
are built into larger structures called the sarcomeres, the con-
tractile unit of a muscle cell. Then, these are built into myofibrils 
which form tissue and surrounds the ventricles of the heart. At 
this present day, technology is unable to engineer something 
this complex starting from the nanometer scale and up. Yet, sci-
entists are able to figure out where they are able to interface 
with the system, by providing information into the biology that 
can guide the living system to do the work of producing the 
components of the microstructures. Once the cells are formed, 
they themselves manufacture the microstructures necessary 
and the 3D bioprinting scaffolds, the suitable base, are used to 
build larger structures up to the size of a whole organ. 
The embryo is a perfect example of biological manufacturing, it 
starts off with one cell and those cells divide and build an extra-
cellular matrix around themselves until there is a full function-
ing organism. The extracellular matrix is a nanofiber network of 
protein and other molecules. It mechanically integrates cells into 
tissues, acts as an insoluble signaling network and functions as a 
scaffold that fills the space between the cells and tissues. This ma-
trix acts as information because it provides cells with instructive 
cues on how to organize and form tissue. It signals between the 
cells using physics, chemistry and mechanics and is integral to 
tissue formation and function (Rozario, Desimone, 2010). A tech-
nique called Bottom Up Engineering of the Extracellular Matrix 
(ECM) was an attempt to build the ECM in the same way cells do; 
from single molecules into a complex 3D fiber with tissue specific 
structure and function according to the organ that is being engi-
neered. This technique thereby accelerates the system of tissue 
formation (Szymanski et. al., 2014).
The idea of using the extracellular matrix is utilized in the fol-
lowing technique for 3D bioprinting organs and other struc-
tures. Soft materials such as collagen and fibrin are difficult for 
scientists to work with because they collapse under their own 
weight and do not have the mechanical strength to be printed 
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in air. To overcome this problem, a gel in gel technique dubbed 
Freeform reversible embedding of suspended hydrogels is used. 
This approach involves soft materials such as fibrin, collagen 
and the polysaccharide alginate. The materials are inside a thick 
slurry of gelatin microparticles and water in a petri dish. The 
semiliquid mixture of gelatin microparticles is able to flow 
around the printing needle as it operates. At the same time, the 
soft biomaterials being released are firmly implanted during the 
layer by layer printing technique. Once the printing of the scaf-
folds is completed, the dish is warmed up to 37 degrees Celsius 
thereby removing the gelatin and revealing the scaffold replica 
of an organ or tissue (Hinton et. al., 2015, Figure 1).
One application of this technique is using magnetic resonance im-
aging (MRI) to print patient specific scaffolds to engineer tissues. 
Through magnetic imaging the right coronary arterial tree is 3D 
printed. The right coronary artery along with the left coronary 
artery supplies blood to the heart. The right coronary artery is 
specifically responsible to supply blood to the right atrium, right 
ventricle, bottom portion of the left ventricle and the back of 
the septum. Additionally, the coronary arteries become blocked 
during a heart attack. The 3D printed artery was made of ECM 
materials such as fibrin, hyaluronic acid and alginate with solid 
walls and an open lumen. On a makerbot 3D printer the artery 
took about one hour to print which is the timeframe within the 
viability of cells. The wall thickness, lumen diameter and density 
can be tailored based on patient anatomy. To evaluate whether 
the 3D printed arterial tree was manifold it was set up in a cus-
tom made 3D printed perfusion fixture. A solution of CaCl₂ and 
0.1% black food coloring was injected into the root of the tree. 
Perfusion was successful and captured on camera. The printed 
coronary artery has not been used for transplants such as a cor-
onary artery bypass, yet this technique is a step up from the cur-
rent printing of just straight tubes. This technique creates more 
complex architecture like the real coronary artery tree that can 
hold a better potential graft (Hinton et. al., 2015, Figure 2).
(D) A model of a section of a human right coronary arterial tree 
from 3D MRI is processed at full scale into machine code for FRESH 
printing  (E) An example of the arterial tree printed in alginate (black) 
and embedded in the gelatin slurry support bath  (F) A section of 
the arterial trees printed in fluorescent alginate (green) and imaged 
in 3D to show the hollow lumen and multiple bifurcations  (G) A 
zoomed-in view of the arterial tree shows the defined vessel wall that 
is <1 mm thick and the well-formed lumen. (H) A dark-field image of 
the arterial tree mounted in a perfusion fixture to position a syringe 
in the root of the tree  (I) A time-lapse image of black dye perfused 
through the arterial tree false-colored at time points of 0 to 6 s to 
show flow through the lumen and not through the vessel wall. Scale 
bars, 4 mm (B), 10 mm (E), 2 5 mm (F), 1 mm (G), and 2 5 mm (H 
and I)  (Hinton et  al , 2015) 
Another application of the Freeform reversible embedding of 
suspended hydrogels technique is used to build the embryonic 
heart. The 3D model of the embryonic chick heart was gen-
erated from 3D optical imaging data of a fluorescently labeled 
5-day-old heart. The embryonic stage is the time when the heart 
muscle forms. It is the only time where the human body has the 
potential to form new heart muscle. In order to accurately 3D 
print an organ, there needs to be accurate data input to the 
system. The first step is the 3D imaging of the embryonic heart 
to identify the ECM macrostructure and microstructure asso-
ciated with myogenesis and vascularization. 3D imaging goes 
through the embryonic heart and images the entire heart, ven-
tricles, and trabeculated tissue together with all the exquisite 
details. A 3D computer model of the trabeculated embryonic 
heart is generated based on confocal imaging of cells and the 
extracellular matrix. Then, based on the computer model the 
3D heart is printed and compared with the computer generat-
ed image (Hinton et. al., 2015, Figure 3). 
Figure 1 (Hinton et. al., 2015)
Freeform reversible embedding of suspended hydrogels 
technique
Figure 2 (Hinton et. al., 2015)
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One step further in 3D cardiac printing is the ability to print 
cardiac cells called organoids. This research called “Body on 
a Chip” is currently ongoing at Wake Forest Baptist Medical 
Center. The research converted human skin cells into a net-
work of functioning heart cells, and also fused them with lab 
grown liver cells using a 3D printer. The heart organoid is able 
to beat because it contains specialized cardiac cells and the cells 
receive correct environmental cues such as keeping them at 
the same temperature as the human body. The organoid heart 
cells are made by genetically modifying adult human skin cells 
into induced pluripotent stem cells. Then, these cells are repro-
grammed to produce the organoids which have a diameter of 
0.25 millimeters. The organoids grow and form balls which then 
are 3D printed into different forms and sizes. These cells will 
create tiny organ-like structures that mimic the function of the 
real organ. The organ structures are then placed on a chip to 
provide for an online monitoring. The ultimate goal is to create 
mini organs to test them with different biological and chemical 
agents and the effectiveness of various treatments against dis-
eases (Wakehealth.edu 2016, Figure 4).
The Kidney
In addition to the great need of heart transplants there is even 
a greater number of patients waiting for a kidney transplant. 
Currently, there are over a hundred thousand people anxiously 
waiting for a lifesaving kidney (OPTN, 2016). The kidneys are 
responsible for removing excess fluid and waste from the blood. 
When the kidneys lose their filtering ability, there is a danger-
ously high level of fluid and waste accumulating in the body. This 
condition is known as kidney failure or end stage kidney disease. 
A kidney transplant procedure is often the best way to treat 
a kidney failure. Only one kidney is necessary to replace two 
failed kidneys, thus making a living donor kidney transplantation 
possible (Kidney.org, 2014). 
A kidney transplant can pose risks to both the donor and the 
recipient. There can be possible surgical complications such as 
pain, infection, blood loss, blood clots, allergic reactions to an-
esthesia, pneumonia, injury to surrounding tissue and organs, or 
even death. There are also long term risks for donating a kidney 
such as hypertension, large amounts of protein in the urine, her-
nia, organ impairment or failure that can lead to the need for di-
alysis or transplantation and can even cause death. Additionally, 
there is the problem of the recipient’s body rejecting the kidney 
as a foreign invader. Just as in a heart transplant, the patient will 
need to remain on immunosuppressants every day to prevent 
rejection of the new kidney. These anti-rejection medications 
have a large number of possible side effects because the body’s 
immune system is suppressed (kidney.org, 2014). 
Dr. Anthony Atala demonstrated an early stage experiment that 
could solve the kidney organ donor problem. The experiment 
uses a 3D printer that contains live cells and kidney shaped struc-
ture of collagen to output a transplantable kidney. A blueprint is 
created through a CT scan that goes layer by layer using com-
puterized morphometric imaging analysis and 3D reconstruction 
which leads to actually imaging the kidneys. The image can even 
do a full 360-degree rotation to analyze the kidney in its full volu-
metric characteristics. This information is then taken and scanned 
into a printing computerized form. The printer is then guided by 
the computer imaging and drips the cells layer by layer over the 
scaffold causing the inert mold to come to life. Overtime, the 
millions of cells begin to communicate and function as one organ. 
It took the research team about seven hours to print the 3D 
kidney structure (Murphy, Atala, 2014, Figure 5, Xu et al., 2013).
Vascularization
The kidney represents a challenge more than other organs due 
to the kidney’s detailed, tiny structures that allow the organ 
Figure 3
Printed embryonic heart scaffolds with complex internal 
and external architectures based on 3D imaging data from 
whole organs
Figure 4 (Wakehealth.edu
3D printed beating, cardiac cells called “organoids)
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to perform its sophisticated filtration job by removing waste 
chemicals from blood and turning the waste into urine. The 
function of removing waste is processed by roughly one million 
nephrons which are tiny vessels made up of even smaller urine 
collecting structures called tubules. The kidneys are also respon-
sible to measure chemicals such as sodium and potassium that 
are then released back into the bloodstream in healthy dosag-
es. The kidney’s complex vascular structure especially poses a 
challenge. The vascular tree of the kidney can come down to 
the size of a capillary about eight microns in diameter. Due to 
the kidney’s complexity, it has not been printed for transplant 
in humans at this present time, however researchers are avidly 
looking for ways to make it a reality and help people suffering 
from dialysis treatments while being on a multiple year waiting 
list for a kidney (Murphy, Atala, 2014). 
For a transplant tissue to thrive, a complex level of vasculariza-
tion must be achieved. To some extent, capillaries can branch 
out from already existing blood vessels and into transplanted 
tissue on their own. Researchers have seen signs of sponta-
neous vascularization in small areas of engineered tissue such as 
in healed rat bone defects around three millimeters in diameter 
(Fielding, Bose, 2013). Rather than letting blood vessels sponta-
neously branch off and expand to engineered tissue, researchers 
are crafting templates for more orderly vascular growth. The 
idea is to create hierarchical microvascular networks that will 
guide the endothelial cells that line blood vessels to form tubes 
along predetermined courses. However, capillaries are small, 
measuring just a few microns in diameter. Therefore, even with 
high resolution printers, such small vascular structures would 
most likely collapse especially when printed into soft, biocom-
patible gel. 
Jennifer Lewis researched the vascularization problem using 
a customized, high resolution 3D printer that can form mi-
crochannels in biocompatible gels. Lewis’s research group is 
able to print hydrogel materials down at the micron length 
scale. The smallest microvascular channel the group was able 
to print was about ten microns in diameter. To solve the prob-
lem of collapsing channels, she prints them in fugitive ink which 
is a substance designed to melt away forming the channels 
pattern. The fugitive ink used is called Pluronic 4127, a gel that 
is often used in eyeglass lense cleanser and cosmetics. Pluronic 
4127 is made up of three parts, the two poles of the molecule 
are hydrophilic while the middle segment is hydrophobic. The 
ink also liquefies when it is cooled down as opposed to most 
materials that solidify when they are cooled down (Wu et. 
al.,2011). 
Lewis also used Pluronic F127 as the matrix for the printed 
channels, but the matrix molecules were modified so that they 
polymerize, and thus solidify, in the presence of UV light. This 
allows the matrix to become firm before cooling the gel so that 
the fugitive ink melts away. Taking advantage of the printer’s fine-
tipped nozzle, the research team printed a capillary network 
of fluorescently labeled fugitive ink into the Jello-like matrix. 
Through this technique, a way to pattern hydrogels with vascu-
lar channels was accomplished (Wu et. al., 2011). The next step 
is to take advantage of the self-organizing quality of endothelial 
cells in the 3-D–printed constructs, seeding the printed vascular 
structures with these blood vessel–lining cells. The self orga-
nizing quality is the tendency of the finest capillaries to grow 
spontaneously out of larger microvascular structures which is 
the work of biology when the cells are given a reasonable envi-
ronment (Perryn et. al., 2008). 
Inspired by some of Lewis’s lab work with “fugitive inks,” Jordan 
Miller, at Rice University, created a technique for 3D printing of 
vasculature-mimicking channels. Using a simple open-source 3D 
printer, Miller and his team constructed a carbohydrate lattice 
made from a combination of simple and complex sugars. There is 
a major difference between Miller’s experiments and those done 
by Jennifer Lewis. Lewis uses machines that are very high-end 
and have incredible precision, but they are not easily duplicated 
by others. Miller saw potential in a cheaper printer called the 
Frostruder, a printer originally used to extrude sugar frosting for 
printing fancy designs onto edible treats. Miller adapted a printer 
to incorporate elements of the Frostruder printer’s design and 
was soon able to print dissolvable lattices of carbohydrate fila-
ments (Miller et. al., 2012). The experiment used a process called 
“3-D sacrificial molding” that is similar to the lost-wax method 
used by sculptors. His printer deposits filaments of carbohydrate 
on top of each other in sequence so they are self-supporting. 
Then the entire lattice structure is covered in a protective layer 
of a biodegradable polymer. After pouring and cross linking a cell-
filled gel over the carbohydrate lattice, the lattice is dissolved with 
an aqueous solution (Miller et. al., 2012).
Figure 5 (Murphy, Atala, 2014) (TED.com 2011)
Dr. Atala holding his printed kidney during a TED talk 
called “On Printing a Human Kidney,” in March 2011.
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Miller’s channels are not as small as Lewis’ channels. His chan-
nels range from 150 microns to around a millimeter in diameter. 
However, when he and colleagues seeded the channels with 
endothelial cells, they lined the interiors of the channels and 
even began to penetrate the surrounding cell-gel mixture. By 
guiding blood cells into the larger channels, he can set the stage 
for endothelial cells to spontaneously form their own capillary 
networks. Miller has successfully pumped human blood through 
his constructs in vitro, and the research team plans to cooper-
ate with a surgeon to connect one of his printed tissues to the 
vascular system of a rat to see how long he can get blood to 
flow through his channels (Miller et. al., 2012).
Vascularization procedures done by Miller and team take a 
short amount of time to complete which benefits the large 
scale tissues, like liver cells. Large scale tissue cannot survive 
the several hours it takes in the extruder nozzle long enough to 
build something the size of the human liver. Additionally, quickly 
pouring the cells and gels over the 3-D–printed lattice is easier 
on fragile cells than the arduous process of printing. The one 
disadvantage is that the researchers cannot control the exact 
placement of the cells. Therefore, this may not be the optimal 
method for experiments involving multiple cell types. In the 
versions of the constructs printed with rat liver cells or with 
human embryonic kidney cells, the cells near the channels sur-
vive longer than the cells deeper in the gel, suggesting that the 
experiment is leading in the right direction (Miller et. al., 2012).
Conclusion
At this present time, a 3D printed organ is unable to be inserted 
into a patient with the same efficacy as a normal organ. Many more 
years of research need to be conducted. There are constantly 
many advances being made by countless numbers of research 
teams who are devoted to help suffering patients and increase 
the availability of organs for transplant. However, even though 3D 
printed organs cannot be inserted into patients, they can be used 
to assist doctors and surgeons in surgery. Advanced models of 
organs that are 3D printed are able to prepare surgeons on what 
they might encounter in the operating room. Simply by looking 
at models, doctors are able to avoid potential complications that 
could have been unforeseeable without the physical model. 3D 
printed organs can also help train medical students and profes-
sionals. Researchers and Doctors are able to replicate the part of 
the patient with the complicated problem so students can learn 
how to go about saving lives. It also allows healthcare profes-
sionals to better explain situations to the patient. The healthcare 
provider can physically hold the model and explain what is wrong 
and the different procedures available for the patient. Currently, 
the main use of the 3D printed organs has been for screening 
new medications and modeling various diseases. 
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